Can a patient receive intramuscular ketorolac (Toradol) and intramuscular methylprednisolone (Solu-Medrol) for back pain, together with her scheduled depot injection, on the same day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can All Three Injections Be Given on the Same Day?

Yes, your patient can safely receive IM ketorolac (Toradol), IM methylprednisolone (Solu-Medrol), and her depot contraceptive injection on the same day, but you should reconsider whether the first two medications are actually indicated for her back pain.

Critical Safety Considerations

Physical Compatibility and Administration

The FDA label for Solu-Medrol explicitly states that "SOLU-MEDROL should not be diluted or mixed with other solutions" 1. This means:

  • Each medication must be drawn up and administered separately
  • Use different injection sites for each medication (e.g., different deltoids, or deltoid vs. ventrogluteal)
  • Avoid the deltoid for Solu-Medrol specifically, as the FDA warns of "high incidence of subcutaneous atrophy" with deltoid injections 1
  • Space the injections at least 2-3 cm apart if using the same general anatomical region

No Drug-Drug Interactions of Concern

There are no documented pharmacologic interactions between ketorolac, methylprednisolone, and depot medroxyprogesterone acetate (assuming this is the depot injection) that would contraindicate same-day administration. The concern is purely about physical compatibility at injection sites and proper technique.

The More Important Question: Should You Give These Medications?

Evidence Against IM Steroids for Back Pain

Recent 2025 BMJ guidelines strongly recommend against intramuscular corticosteroid injections for chronic back pain 2. The guideline found:

  • Low certainty evidence that IM injection of local anesthetic with steroids may actually increase pain compared to sham procedures
  • Serious adverse events reported with corticosteroid injections including death, spinal cord infarction, paraplegia, stroke, and seizures (90 cases captured by FDA between 1997-2014) 2
  • 8.6% risk of prolonged pain/stiffness, 2.1% risk of altered consciousness, 1.4% risk of dural puncture 2

A 2022 Cochrane review found that systemic corticosteroids for radicular low back pain provide only minimal short-term benefit (0.56 points on 0-10 scale) and may slightly improve function, but effects are modest 3.

Evidence for Ketorolac

Ketorolac does provide effective analgesia for acute musculoskeletal back pain:

  • Comparable efficacy to oral ibuprofen 400mg 4
  • Effective for postoperative lumbar spine pain with opioid-sparing effects 5
  • However, risks increase with prolonged use (>5 days), high doses, or in elderly patients 6
  • Contraindications include GI bleeding risk, renal impairment, compromised hemostasis 6

Practical Algorithm for This Patient

Step 1: Assess Appropriateness

  • Is this acute (<6 weeks) or chronic back pain?

    • If chronic: Do not give IM Solu-Medrol (no evidence of benefit, potential for harm) 2
    • If acute radicular pain: Solu-Medrol may provide minimal benefit but consider oral alternatives 3
  • Does the patient have contraindications to ketorolac?

    • Age >65, renal disease, GI bleeding history, anticoagulation, aspirin allergy → Do not give 6
    • If appropriate: Limit to ≤5 days total duration 6

Step 2: If Proceeding with All Three Injections

Injection sequence and sites:

  1. Depot contraceptive: Ventrogluteal or deltoid (standard site per product)
  2. Ketorolac 10-30mg IM: Opposite ventrogluteal or deltoid from depot
  3. Solu-Medrol 40-80mg IM: Ventrogluteal only (avoid deltoid due to atrophy risk) 1

Technique considerations:

  • Inject Solu-Medrol slowly over 30 seconds (reduces pain compared to 10-second injection) 7
  • Ensure at least 2-3 cm separation between injection sites
  • Do not mix medications in the same syringe 1

Step 3: Patient Counseling

Warn the patient about:

  • Injection site pain (more common with ketorolac) 4
  • Potential for increased back pain in first 48 hours (paradoxical effect of steroids) 2
  • GI upset risk with ketorolac
  • Need for follow-up if symptoms worsen

Better Alternative Approach

Consider offering instead:

  • Oral NSAIDs (ibuprofen 400-600mg) - equally effective as IM ketorolac 4
  • Oral corticosteroids if radicular symptoms present (similar efficacy to IM, easier to titrate) 3
  • Proceed with depot contraceptive as scheduled
  • This avoids multiple painful injections with questionable added benefit

The depot contraceptive can absolutely be given the same day as the other medications without concern for interaction or reduced efficacy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.